- Home
- TIC vs OCUL Comparison
TIC vs OCUL Comparison
Compare TIC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIC
- OCUL
- Stock Information
- Founded
- TIC 1991
- OCUL 2006
- Country
- TIC United States
- OCUL United States
- Employees
- TIC N/A
- OCUL N/A
- Industry
- TIC
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- TIC
- OCUL Health Care
- Exchange
- TIC Nasdaq
- OCUL Nasdaq
- Market Cap
- TIC 1.3B
- OCUL 1.4B
- IPO Year
- TIC N/A
- OCUL 2014
- Fundamental
- Price
- TIC $11.44
- OCUL $11.03
- Analyst Decision
- TIC Hold
- OCUL Strong Buy
- Analyst Count
- TIC 1
- OCUL 7
- Target Price
- TIC $11.50
- OCUL $17.33
- AVG Volume (30 Days)
- TIC 2.3M
- OCUL 2.4M
- Earning Date
- TIC 08-03-2025
- OCUL 08-06-2025
- Dividend Yield
- TIC N/A
- OCUL N/A
- EPS Growth
- TIC N/A
- OCUL N/A
- EPS
- TIC N/A
- OCUL N/A
- Revenue
- TIC $1,108,546,000.00
- OCUL $59,647,000.00
- Revenue This Year
- TIC $4.52
- OCUL N/A
- Revenue Next Year
- TIC $5.23
- OCUL $20.05
- P/E Ratio
- TIC N/A
- OCUL N/A
- Revenue Growth
- TIC 9.12
- OCUL N/A
- 52 Week Low
- TIC $8.76
- OCUL $5.79
- 52 Week High
- TIC $14.28
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- TIC N/A
- OCUL 76.75
- Support Level
- TIC N/A
- OCUL $9.36
- Resistance Level
- TIC N/A
- OCUL $9.75
- Average True Range (ATR)
- TIC 0.00
- OCUL 0.54
- MACD
- TIC 0.00
- OCUL 0.18
- Stochastic Oscillator
- TIC 0.00
- OCUL 91.46
About TIC Acuren Corporation Common Stock
Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.